G L O B A L H U M A N H E A L T H B U S I N E S S D E V E L O P M E N T

WELCOMINGNEW OPPORTUNITIES FOR

COMMERCIAL PARTNERSHIPS Uniquely positioned to maximize your products and technologies

At Merck, we share your vision for operational excellence, delivering commercial success, significantly enhancing revenue streams and operating income, and maximizing the value of the brand across its life cycle.

A dedicated team of functional experts representing, amongst others, regulatory affairs, market access, commercial operations, manufacturing, trademark, and medical affairs are available to work with you to jointly deliver on brand promise. Our commercial footprint and operating model provide us with a flexible and innovative approach to customers. Be it for one country, one region, or worldwide, we apply the same rigour in our processes and resource allocation with the goal of ensuring a mutually beneficial collaboration.

Merck continues to pursue business development opportunities across the world, in our key franchise areas, and including therapeutic treatments, new technologies, and devices that complement our portfolio.

Typical partnerships can include, but are not limited to:

• Co-Promotion

• Co-Marketing

• Distribution

• Commercial Collaboration

In response to the increasing risk and costs involved in commercializing products, we are open to explore more creative ways of partnering that can transform a partnership into a long-term strategic alliance.

C O M B I N I N G O U R S T R E N G T H S …

Atherosclerosis and Cardiovascular

Diseases

Immunology Respiratory Diabetes and Endocrinology

Infectious Diseases

We leverage our global marketing and sales expertise to achieve commercial success with our partners through:

• Customer Business Lines to maximize the potential of our product portfolio with our customers around the world and to align with business and commercial operations across customer groups at the global, regional, and country levels

• Marketing success through clear positioning of the product's unique benefits in order to gain rapid and optimal market access

• Commitment to continuous innovation by identifying new indications, patient populations, and innovative formulations that maximize growth potential

• Defined customer needs that comprise highly effective traditional and alternative marketing channels

• Global reach and highly skilled sales force in primary, specialist, and hospital care

At Merck we are uniquely positioned to work with you, become part of the same marketing community, and thus maximize our respective assets. A few recent partnering examples include:

• Roche promotion of Victrelis® on a global basis

• Lundbeck multi-regional commercialization agreement for Sycrest®

• Santen multi-regional licensing agreement for tafluprost which covers the U.S. and select European countries

• Sun Emerging Markets joint venture

• Siemens Europe/Canada/Latin America, collaboration with Siemens Diagnostics

• Simcere China joint venture

At the core of each successful partnership is a close relationship based on trust and mutual respect. Merck is committed to ensuring that our partnerships succeed and flourish. Signing the agreement is only the first step. Your Alliance Manager is committed to ensuring that, throughout our collaboration, our teams will work together in all relevant domains. Your Alliance Manager provides a clear and enriching channel of communication, ensuring transparent and candid dialogue. Together we will monitor our shared progress and work towards shared success.

… S H A R I N G O U R S U C C E S S E S

Neurosciences and Ophthalmology

Oncology Vaccines Women’s Health

E M B R A C I N G C O M M E R C I A L P A R T N E R S H I P S

Headquarters Contacts:

Regional Contacts:

GLOBAL LEADER

EUROPE AND CANADA

JAPAN

EMERGING MARKETS

UNITED STATES

THERAPEUTIC AREAS

Laura LevineVice President, Global Human HealthBusiness Development and Alliance ManagementMerck & Co., Inc. PO Box 100 Whitehouse Station, NJ, USA 08889Email: laura.levine@merck.comPhone: +1 (908) 423-5222

Alet VerbeekExecutive Director, Global Human Health Business Development: Europe and CanadaMSD Clos du Lynx 5 1200 Woluwe, Belgium Email: alette.verbeek@merck.com Phone: +32 2 776 65 58

Ryota SakuraiDirector, Global Human Health Business Development: JapanMSD K.K.Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku Tokyo 102-8667, Japan Email: ryota.sakurai@merck.com Phone: +81 3 6272 1027

For more information, please visit us at www.merck.com/partnering

Branimir BrankovExecutive Director, Global Human Health Business Development: Emerging MarketsMerck & Co., Inc. PO Box 100 Whitehouse Station, NJ, USA 08889 Email: branimir.brankov@merck.com Phone: +1 (908) 423-4847

John CopelandExecutive Director, Global Human Health Business Development: USMerck & Co., Inc. UG2A-12351 North Sumneytown PikeNorth Wales, PA, USA 19454Email: john.copeland@merck.comPhone: +1 (267) 305-2809

Stephen TulejaExecutive Director, Global Human HealthBusiness Development: FranchisesMerck & Co., Inc. PO Box 100 Whitehouse Station, NJ, USA 08889Email: stephen.tuleja@merck.comPhone: +1 (908) 423-6969